PROK vs SPY
ProKidney Corp. (PROK) versus SPDR S&P 500 ETF Trust (SPY) — a side-by-side from cached financials, not a winner call.
ProKidney Corp. (PROK) is a biotechnology company listed on US.
SPDR S&P 500 ETF Trust (SPY) common stock listed on US.
Latest reported PROK revenue for 2026-06-30 was $376.0K. Net income was -$48.5M. Revenue was up 66.4% from 2026-03-31 to 2026-06-30. PROK currently screens at market cap $543.7M.
SPY does not have a complete income-statement cache yet.
PROK currently screens at market cap $543.7M. SPY currently screens at market cap $0.
Not investment advice. Open the PROK and SPY stock pages for the full models.
Not investment advice.